Detalhe da pesquisa
1.
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
J Am Coll Cardiol;
83(23): 2324-2405, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727647
2.
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
Circulation;
149(23): e1239-e1311, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38718139
3.
A Customizable and Peer-Reviewed Curriculum for Cardiovascular Genetics and Genomics.
Circulation;
149(12): 902-904, 2024 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38498607
4.
Genetic Testing in Hypertrophic Cardiomyopathy.
Am J Cardiol;
212S: S4-S13, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368035
5.
Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in Genetic Hypertrophic Cardiomyopathy.
Circulation;
149(2): 107-123, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37929589
6.
International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review.
J Am Coll Cardiol;
82(16): 1628-1647, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821174
7.
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
JAMA Cardiol;
8(11): 1083-1088, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37672268
8.
Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy: JACC: Heart Failure State-of-the-Art Review.
JACC Heart Fail;
11(7): 735-748, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407153
9.
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
Circulation;
148(5): 394-404, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226762
10.
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy.
JAMA Cardiol;
8(6): 595-605, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195701
11.
Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy.
Circ Heart Fail;
16(6): e010291, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880380
12.
Transforming Growth Factor-ß Analysis of the VANISH Trial Cohort.
Circ Heart Fail;
16(4): e010314, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999957
13.
Large scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy.
medRxiv;
2023 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36778260
14.
3-Dimensional Strain Analysis of Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM Registry.
JACC Cardiovasc Imaging;
16(4): 478-491, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648040
15.
Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy.
Circ Genom Precis Med;
16(1): e003716, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36598836
16.
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry.
ESC Heart Fail;
9(4): 2189-2198, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36255281
17.
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model.
Proc Natl Acad Sci U S A;
119(28): e2204174119, 2022 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35787042
18.
External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy.
Eur J Prev Cardiol;
29(4): 678-686, 2022 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718528
19.
Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy.
J Am Coll Cardiol;
78(25): 2518-2532, 2021 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915982
20.
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial.
Nat Med;
27(10): 1818-1824, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34556856